After reviewing an impressive pool of 26 applicants, the KL2 Clinical Scholar Program is pleased to announce its new cohort (pictured above, from left):
Matthew Campbell, M.D., Assistant Professor of Pediatrics – A pediatric hematologist and oncologist, Dr. Campbell's research interests include musculoskeletal tumors and cellular and immune therapies.
Sanjay Chandrasekaran, M.D., Assistant Professor in the Department of Internal Medicine – Dr. Chandrasekaran specializes in hematology and oncology, with a focus on melanoma, advanced skin cancer, and soft tissue and bone sarcomas.
Erica Jones, M.D., Assistant Professor of Neurology – Dr. Jones’ clinical and research interests include health disparities in stroke care, global access to stroke care, and the effect of social determinants of health on stroke outcomes.
Bethany Roehm, M.D., Assistant Professor in the Department of Internal Medicine – Dr. Roehm's research covers the areas of general nephrology, heart failure in kidney disease patients, and hypertension.
Over the next two years the new scholars will have time and resources to develop their research and be ready to transition into independently funded scientists.
The KL2 Clinical Scholar Program provides research and career development support from the National Center for Advancing Translational Sciences (NCATS) for junior faculty engaged in clinical research. It is sponsored by the Clinical and Translational Science Award (CTSA) Program.
|